ALK and neuroblastoma: The developed CAR-T cell surface targets for NB are GD2, L1-CAM, GPC2, B7H3, ALK, and NCAM. ALK CAR-T can target wild-type and mutant ALK, and CAR-T cells targeting GD2 and L1-CAM are currently in clinical trials (Richards et al., 2018).